Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

12.9K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.9K
Amyloid Fibrils03:03

Amyloid Fibrils

6.9K
6.9K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trees as a metaphor to understand relationships in biology.

PLoS biology·2024
Same author

Addressing biodiversity loss by building a shared future.

PLoS biology·2022
Same author

The first six years of meta-research at PLOS Biology.

PLoS biology·2022
Same author

Mitochondria-A billion years of cohabitation.

PLoS biology·2017
Same author

Living Life on a Magnet.

PLoS biology·2016
Same author

Toxoplasma's Taste for Exotic Fat.

PLoS biology·2015

Related Experiment Video

Updated: Mar 26, 2026

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
10:19

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on: August 14, 2016

9.8K

Good Amyloid, Bad Amyloid-What's the Difference?

Roland G Roberts1

  • 1Public Library of Science, Cambridge, United Kingdom.

Plos Biology
|January 27, 2016
PubMed
Summary
This summary is machine-generated.

Functional amyloids, like Orb2, can be beneficial or harmful. This study reveals that the speed of amyloid formation determines whether Orb2 protein aggregation leads to disease or serves a biological purpose.

More Related Videos

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

19.4K
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
04:41

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

24.1K

Related Experiment Videos

Last Updated: Mar 26, 2026

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
10:19

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on: August 14, 2016

9.8K
Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

19.4K
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
04:41

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

24.1K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Amyloid proteins are implicated in both neurodegenerative diseases and essential biological functions.
  • The differing roles of amyloids suggest regulatory mechanisms controlling their aggregation and function.
  • The functional amyloid Orb2, crucial for memory, provides a model to investigate these mechanisms.

Purpose of the Study:

  • To investigate the role of aggregation kinetics in determining the functional or pathological outcomes of amyloid proteins.
  • To elucidate how the formation speed of the Orb2 amyloid impacts its biological role and potential for disease.

Main Methods:

  • Utilized in vitro kinetic studies to analyze Orb2 amyloid formation rates.
  • Employed biochemical assays to assess the functional consequences of different Orb2 aggregation speeds.
  • Investigated the structural characteristics of Orb2 aggregates formed under varying kinetic conditions.

Main Results:

  • Orb2 aggregation speed is a critical determinant of its functional outcome.
  • Rapid Orb2 amyloid formation is associated with its normal biological function, such as in memory consolidation.
  • Slower or aberrant Orb2 aggregation kinetics correlate with potential pathological states.

Conclusions:

  • The kinetics of amyloid formation, specifically the speed, dictates whether a functional amyloid like Orb2 is beneficial or detrimental.
  • Understanding these aggregation dynamics is key to differentiating beneficial amyloids from those causing neurodegeneration.
  • This research offers insights into therapeutic strategies targeting amyloid-related disorders by modulating protein aggregation speed.